168 related articles for article (PubMed ID: 24252805)
1. Biofilm-dependent airway infections: a role for ambroxol?
Cataldi M; Sblendorio V; Leo A; Piazza O
Pulm Pharmacol Ther; 2014 Aug; 28(2):98-108. PubMed ID: 24252805
[TBL] [Abstract][Full Text] [Related]
2. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
3. The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections.
Blasi F; Page C; Rossolini GM; Pallecchi L; Matera MG; Rogliani P; Cazzola M
Respir Med; 2016 Aug; 117():190-7. PubMed ID: 27492531
[TBL] [Abstract][Full Text] [Related]
4. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
Zhang SJ; Jiang JX; Ren QQ; Jia YL; Shen J; Shen HJ; Lin XX; Lu H; Xie QM
Eur J Pharmacol; 2016 Mar; 775():138-48. PubMed ID: 26872986
[TBL] [Abstract][Full Text] [Related]
5. Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway.
Ge LT; Liu YN; Lin XX; Shen HJ; Jia YL; Dong XW; Sun Y; Xie QM
Int Immunopharmacol; 2016 Apr; 33():90-8. PubMed ID: 26881857
[TBL] [Abstract][Full Text] [Related]
6. The effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells.
Varelogianni G; Hussain R; Strid H; Oliynyk I; Roomans GM; Johannesson M
Cell Biol Int; 2013 Nov; 37(11):1149-56. PubMed ID: 23765701
[TBL] [Abstract][Full Text] [Related]
7. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model.
Lu Q; Yu J; Bao L; Ran T; Zhong H
Chemotherapy; 2013; 59(1):51-6. PubMed ID: 23816803
[TBL] [Abstract][Full Text] [Related]
8. Ambroxol in the 21st century: pharmacological and clinical update.
Malerba M; Ragnoli B
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1119-29. PubMed ID: 18680446
[TBL] [Abstract][Full Text] [Related]
9. Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
Pulcrano G; Panellis D; De Domenico G; Rossano F; Catania MR
FEMS Yeast Res; 2012 Jun; 12(4):430-8. PubMed ID: 22315984
[TBL] [Abstract][Full Text] [Related]
10. [Effect of ambroxol on biofilm of Haemophilus influenzae and bactericidal action].
Gao X; Zhang Y; Lin Y; Li H; Xin Y; Zhang X; Xu Y; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 May; 28(10):721-3. PubMed ID: 25129975
[TBL] [Abstract][Full Text] [Related]
11. Effect of ambroxol on pneumonia caused by Pseudomonas aeruginosa with biofilm formation in an endotracheal intubation rat model.
Li F; Wang W; Hu L; Li L; Yu J
Chemotherapy; 2011; 57(2):173-80. PubMed ID: 21454975
[TBL] [Abstract][Full Text] [Related]
12. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
13. Ambroxol interferes with Pseudomonas aeruginosa quorum sensing.
Lu Q; Yu J; Yang X; Wang J; Wang L; Lin Y; Lin L
Int J Antimicrob Agents; 2010 Sep; 36(3):211-5. PubMed ID: 20580207
[TBL] [Abstract][Full Text] [Related]
14. The potential role of natural agents in treatment of airway inflammation.
Sharafkhaneh A; Velamuri S; Badmaev V; Lan C; Hanania N
Ther Adv Respir Dis; 2007 Dec; 1(2):105-20. PubMed ID: 19124352
[TBL] [Abstract][Full Text] [Related]
15. [More than expectorant: new scientific data on ambroxol in the context of the treatment of bronchopulmonary diseases].
Plomer M; de Zeeuw J
MMW Fortschr Med; 2017 Jun; 159(Suppl 5):22-33. PubMed ID: 28643291
[TBL] [Abstract][Full Text] [Related]
16. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels.
Yang B; Yao DF; Ohuchi M; Ide M; Yano M; Okumura Y; Kido H
Eur Respir J; 2002 May; 19(5):952-8. PubMed ID: 12030738
[TBL] [Abstract][Full Text] [Related]
17. [Modification of mucociliary clearance by a combination of theophylline with ambroxol and of ambroxol in monotherapy].
Dorow P; Weiss T
Arzneimittelforschung; 1988 Jun; 38(6):828-30. PubMed ID: 3052462
[TBL] [Abstract][Full Text] [Related]
18. [Effects of topical agents for burns on Acinetobacter baumannii within biofilm].
Huang XQ; Xiang J; Song F; Huan JN
Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):106-10. PubMed ID: 22781321
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory properties of ambroxol.
Beeh KM; Beier J; Esperester A; Paul LD
Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
[TBL] [Abstract][Full Text] [Related]
20. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
